Correction: Expanded Access Study of Palbociclib Plus Letrozole for Postmenopausal Women with HR+/HER2− Advanced Breast Cancer in Latin America for Whom Letrozole Therapy is Deemed Appropriate. - Fein, Luis; Lazaretti, Nicolas; Chuken, Yamil López; Benfield, J. Rogelio González Ramírez; Mano, Max S.; Lobaton, Jose; Korbenfeld, Ernesto; Damian, Fernanda; Lu, Dongrui R.; Mori, Ave; Patyna, Shem J.; Franco, Sandra (Clinical Drug Investigation, 2023)